Skip to content
  • Contact Us
  • Request Samples
  • Order
Mill Creek Life Sciences
  • Our Technology
    • Human Platelet Lysate
    • Applications
    • Dendritic Cell Vaccine
  • Products
    • PLTMax®
    • PLTGold®
    • Order
    • Request Samples
  • Support
    • Technical Support
    • Publications
    • Posters
    • Distributors
    • FAQs
    • Contact Us
  • About Us
    • Our Company
    • Quality
    • News
    • Collaborate
    • Careers
Filters (4)
Filters
  • Reset all ×
  • Pre-clinical studies ×
  • Kidney ×

4 resources found

    N/A
Show (4)
Cancel

Alterations in genetic and protein content of swine adipose tissue-derived mesenchymal stem cells in the Metabolic Syndrome (May 2019)

Targeting Murine Mesenchymal Stem Cells to Kidney Injury Molecule-1 Improves Their Therapeutic Efficacy in Chronic Ischemic Kidney Injury (May 2018)

Adipose-derived mesenchymal stem cells from patients with atherosclerotic renovascular disease have increased DNA damage and reduced angiogenesis that can be modified by hypoxia (Sep 2016)

Renal vein cytokine release as an index of renal parenchymal inflammation in chronic experimental renal artery stenosis (Feb 2014)

MillCreek_Logo.rev.v

Mill Creek Life Sciences, Inc.
221 1st Avenue SW, Suite 209
Rochester, MN 55902, USA

Phone: 507-287-6257
Fax: 507-289-2066
Email: info@millcreekls.com

OUR TECHNOLOGY

Human Platelet Lysate

Applications

Dendritic Cell Vaccine

PRODUCTS

PLTMax®

PLTGold®

Order

Request Samples

SUPPORT

Technical Support

Publications

Posters

Distributors

FAQs

Contact Us

ABOUT US

Our Company

Quality

News

Collaborate

Careers